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AbstrAct
background Early-onset neonatal sepsis (EOS) is 
a serious and potentially life-threatening disease in 
newborns. C reactive protein (CRP) is the most used 
laboratory biomarker for the detection of EOS. Little is 
known about normal reference values of CRP during the 
perinatal period as several factors are able to influence 
it.
Objectives To identify an appropriate range of CRP 
values in healthy term newborns during the first 48 hours 
of life.
Design CRP determination was performed in 859 
term newborns at 12, 24 and 48 hours of life. Mode of 
delivery, maternal vaginal culture results, intrapartum 
antimicrobial prophylaxis (IAP) and other perinatal 
variables were recorded.
results CRP mean values were significantly higher at 
48 hours (4.10 mg/L) than at both 24 (2.30 mg/L) and 
12 hours of life (0.80 mg/L). CRP levels were affected 
by a number of perinatal proinflammatory variables. 
In particular, CRP mean values were significantly 
higher in babies born by vaginal delivery (3.80 mg/L) 
and emergency caesarean section (3.60 mg/L) than in 
babies born by elective caesarean section (2.10 mg/L). 
Completed course of IAP led to lower CRP mean values 
(2.90 mg/L) than IAP not completed (3.80 mg/L) or not 
performed (4.70 mg/L).
conclusions Postnatal age and mode of delivery 
significantly influence CRP values. Reliable reference 
values are crucial in order to obtain an adequate 
diagnostic accuracy.
IntrODuctIOn
C reactive protein (CRP) is an acute phase reac-
tant protein and a marker of systemic inflamma-
tion produced by the liver. High CRP levels are 
known to be associated with early-onset neonatal 
sepsis (EOS), which is a serious and potentially 
life-threatening disease in newborns. EOS has a 
mortality rate around 1.5% in term newborns and 
up to 40% in very-low-birth-weight infants.1 The 
aetiology of EOS is various, but group B Strepto-
coccus (GBS) (also known as Streptococcus agalac-
tiae) has a central role.2 Early recognition of EOS in 
newborns still remains challenging due to the high 
variability of the clinical spectrum and the subtle 
and non-specific signs and symptoms of neonatal 
sepsis that are clinically indistinguishable from 
other non-infectious conditions, such as respiratory 
distress syndrome or difficult adaptation to extra-
uterine life.3 4
Numerous biomarkers have been proposed to 
distinguish septic babies from healthy ones.5–9 The 
determination of CRP, in consideration of its huge 
availability, simplicity, speed and low cost, plays 
a central role in the diagnosis of EOS, therefore 
representing the most used marker in neonatal 
intensive care units (NICUs) all over the world. 
Although a huge body of literature is available on 
CRP in newborns, some issues have not yet been 
fully dealt with, such as the influence of non-infec-
tious factors on CRP levels.
CRP levels in fact increase in all conditions able 
to activate the inflammatory cascade and/or tissue 
damage1: many prenatal, perinatal and neonatal 
factors might have an influence on CRP concentra-
tions, so that an increased CRP is not necessarily 
linked to a septic status. The identification of inde-
pendent variables influencing the interpretation 
of CRP may be useful in the differential diagnosis 
of EOS. Moreover, CRP levels physiologically 
increase in newborns within the first days of life. 
It is therefore mandatory to consider the normal 
CRP kinetics, as well as its behaviour in response to 
potential confounders, when evaluating a newborn 
What this study adds?
 ► It is normal for CRP values to rise after 
delivery, up to 20 mg/L at 48 hours.
 ► CRP values are higher after normal delivery 
and emergency caesarean section compared 
with elective caesarean section.
 ► Guidelines for the interpretation of CRP values 
in apparently low-risk neonates may need to be 
reconsidered in the light of these data.
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What is already known on this topic?
 ► C reactive protein (CRP) is the most used 
marker in neonatal care all over the world.
 ► CRP reference values during the first hours of 
life have mainly been established in uninfected 
but symptomatic newborns and/or on relatively 
small populations.
 ► The association between CRP and 
non-infectious conditions is not completely 
clear as the majority of studies were performed 
on populations with wide-ranging inclusion 
criteria.
 ADC-FNN Online First, published on June 30, 2017 as 10.1136/archdischild-2016-312506
Copyright Article author (or their employer) 2017. Produced by BMJ Publishing Group Ltd (& RCPCH) under licence. 
group.bmj.com on October 9, 2017 - Published by http://fn.bmj.com/Downloaded from 
F2 Perrone S, et al. Arch Dis Child Fetal Neonatal Ed 2017;0:1–4. doi:10.1136/archdischild-2016-312506
table 1 Clinical characteristics of study population
Mean (±sD) or 
frequencies (%) 
(total n=859)
Gestational age (weeks) 39.3 (±1.8)
Birth weight (g) 3322.4 (±443.7)
Gender M 407 (47.4%)
F 452 (52.6%)
Mode of delivery Vaginal delivery 636 (74.04%)
Elective caesarean section 148 (17.23%)
Emergency caesarean section 75 (8.73%)
Apgar score 1 min 9.1 (±0.8)
5 min 9.5 (±0.4)
Maternal vaginal culture 
for GBS
Negative 240 (27.94%)
Positive 208 (24.21%)
Not done or remote 
(done >4 weeks before the delivery)
411 (47.85%)
IAP to the mothers Complete IAP (two doses) 179 (20.84%)
Incomplete IAP (only one dose) 236 (27.47%)
IAP not done 444 (51.69%)
Meconium-stained 
amniotic fluid
72 (8.38%)
PROM >18 hours 107 (12.45%)
F, female; GBS, group B Streptococcus; IAP, intrapartum antimicrobial prophylaxis; 
M, male; PROM, premature rupture of membranes.
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in the first hours of life in order to avoid inaccurate diagnosis 
and inappropriate treatment.
The aim of our study is to assess trend and normal range 
values of CRP in a large and homogeneous cohort of term 
newborns during the first 48 hours of life and the potential influ-
ence exerted by perinatal variables.
MethODs
Patients
A prospective study was conducted in the department of 
molecular and developmental medicine at the Siena University 
Hospital, Italy, between January 2014 and December 2015. The 
local ethics board approved the study protocol. A total of 859 
consecutively born healthy term newborns were enrolled. For 
clinical details, see table 1.
Informed consent was obtained from the babies’ parents 
before the enrolment.
Inclusion criteria were as follows: (A) gestational age 37–42 
weeks; (B) at least one CRP determination in the first 48 hours 
of life; (C) continuous uncomplicated postnatal hospital stay and 
discharge as healthy from the hospital at 48 hours of life (if born 
by vaginal delivery) or at 72 hours of life (if born by caesarean 
section); (D) informed consent signed by a parent/legal guardian.
Exclusion criteria were considered as follows: (A) antibiotic 
therapy in the first 48 hours of life; (B) babies with congenital heart 
malformation, major congenital malformations and/or chromo-
somal anomalies; babies who received anti-hepatitis B vaccine; 
(C) clinical signs of chorioamnionitis (maternal fever >38°C; 
maternal leucocytosis; maternal tachycardia >100 beats per 
minute (bpm); fetal tachycardia >160 bpm); (d) babies who 
needed intensive assistance and were hospitalised in NICU; (E) 
acute intrapartum events such as cord prolapse, uterine rupture, 
sudden and sustained fetal bradycardia, shoulder dystocia and 
complicated breech extraction; and (F) clinical signs of prenatal/
perinatal asphyxia (metabolic or mixed acidaemia (pH <7.00) 
in umbilical artery blood sample, if obtained; persistence of an 
Apgar score of 0–3 for longer than 5 min; neonatal neurological 
sequelae and multiple organ involvement).
None of the enrolled newborns developed sepsis; none of 
them was readmitted to the hospital within the first month of 
life.
All the antepartum and intrapartum data were collected, 
including mode of delivery, duration of active labour, interval 
between rupture of membranes and delivery, presence of meco-
nium-stained or  fetid amniotic fluid, maternal vaginal culture 
for GBS and administration of intrapartum antibiotic prophy-
laxis (IAP) to the mothers.
In our hospital, the revised guidelines from the Centers for 
Disease Control and Prevention (CDC)10 for prevention of peri-
natal group B streptococcal disease are in force: each woman 
with a positive or unknown swab for GBS at the 35th–37th 
weeks of gestation is a candidate for the administration of antibi-
otic therapy during labour. The same treatment is performed in 
cases of unknown swab for GBS if either or both of the following 
risk factors are present: maternal fever or premature rupture of 
membranes (PROM) longer than 18 hours.10
In all babies, CRP was determined in the first 48 hours of life, 
according to an internal protocol. In particular, CRP evaluations 
were performed at 12, 24 and/or 48 hours of life with venipunc-
ture together with routine blood tests or compulsory samples for 
screening of metabolic diseases. The adequate amount of blood 
required for the analysis was around 0.5 mL.
For the quantitative determination of CRP in human serum 
and plasma, we used Roche/Hitachi cobas c systems (CPLRX: 
ACN 019). It is a particle-enhanced immunoturbidimetric assay. 
Human CRP agglutinates with latex particles coated with mono-
clonal anti-CRP antibodies. The precipitate is determined turbi-
dimetrically.
statistics
Descriptive analysis of the variables of the study population 
was performed. CRP levels at 12, 24 and 48 hours of life were 
comparatively analysed using an unpaired t-test, and the signif-
icance level was set at 0.05. When the assumption of uniform 
variance was violated, we used the Satterthwaite approximation 
based on t distribution.11 In order to compare distributional 
aspects, the median and 5th–95th centiles were computed. Then 
CRP levels for neonates born by vaginal delivery (VD), emer-
gency caesarean section (EMCS) and elective caesarean section 
(ELCS) at 48 hours of life were comparatively analysed using a 
unpaired t-test. Also, in this last case to compare distributional 
aspects, the median and 5th–95th centiles were computed. 
Power analysis was not performed because the difference was 
observed at prearranged significance level sets. The data analysis 
was conducted using Statgraphics V.17.2.02.
results
Perinatal characteristics of the newborns are described in table 1.
CRP mean and median values were higher at 48 hours than at 
both 24 and 12 hours of life (table 2  and figure 1).
Each pair of medians (CRP at 12 hours vs CRP at 24 hours, 
CRP at 12 hours vs CRP at 48 hours and CRP at 24 hours vs CRP 
at 48 hours) was statistically different (figure 2).
Neonates born by VD and EMCS showed significantly 
higher CRP mean and median values at 48 hours than those 
born by ELCS. No significant differences were found in CRP 
values between neonates born by VD and those born by EMCS 
(table 3 and figure 3).
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table 2 Mean, median and 5th–95th centiles for C reactive protein 
(CRP) at 12, 24 and 48 hours
Mean (mg/l) Median (mg/l)
Fifth centile 
(mg/l)
95th centile 
(mg/l)
CRP 12 hours 0.80 0.40 0.10 2.60
CRP 24 hours 2.30 1.50 0.30 6.90
CRP 48 hours 4.10 2.70 0.50 13.3
Figure 1 Box and whisker plot for C reactive protein (CRP) at 12, 
24 and 48 hours.
Figure 2 Median and 5th–95th centiles for C reactive protein (CRP) at 
12, 24 and 48 hours.
table 3 Mean, median, 5th–95th centiles for neonates born 
by vaginal delivery (VD), elective caesarean section (ELCS) and 
emergency caesarean section (EMCS) at 48 hours
Mean (mg/l) Median (mg/l)
5th centile 
(mg/l)
95th centile 
(mg/l)
VD 3.80 2.50 0.50 12.1
ELCS 2.10 1.30 0.30 6.00
EMCS 3.60 2.00 0.50 11.3
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Neonates born to mothers who completed the course of IAP 
for the presence of a positive vaginal swab for GBS had signifi-
cantly lower mean values of CRP (2.90 mg/L, 95% CI 2.40 to 
3.30) than neonates whose mothers did not complete IAP 
(3.80 mg/L, 95% CI 3.10 to 4.40) or did not performed IAP 
(4.70 mg/L, 95% CI 4.00 to 5.30), with p<0.05.
Among the antenatal and perinatal variables, PROM, 
prolonged labour and presence of meconium-stained amniotic 
fluid showed a significant effect on CRP levels: newborns with 
at least one of the considered variables had significantly higher 
CRP mean values than babies who had an essentially uneventful 
perinatal and postnatal course (6 mg/L, 95% CI 4.30 to 7.70 vs 
4.10 mg/L, 95% CI 3.70 to 4.40).
DIscussIOn
The main purpose of this study was to examine neonatal CRP 
values in the first hours of life in healthy term newborns and 
CRP modifications in relation to different perinatal conditions. 
When evaluating CRP in a newborn with suspected EOS, it is 
recommendable to consider its normal dynamics and trend in 
the healthy newborn: the selection of a particular CRP value as 
‘normal’ or ‘abnormal’ regardless of potential influencing factors 
may lead to administration of antibiotics to newborns in whom 
the diagnosis of EOS will be ruled out 48–72 hours later with the 
normalisation of diagnostic biomarkers.12
Upper CRP cut-off values during the first days of life have 
mainly been established from studies on uninfected but symp-
tomatic newborns. There are few studies assessing CRP refer-
ence values in healthy neonates, but those observations were 
based on rather small populations.1 In our study, the analysis of 
a large population of healthy term newborns shows that CRP 
values undergo a non-specific rise after birth, consistently with 
the results of previous studies.13 In a research by Chiesa et al,13 
the authors demonstrated that in addition to postnatal age, also 
gestational age has a positive effect on CRP: in fact, preterm 
babies showed a lower and shorter CRP response compared with 
full-term babies.13
It is likely that the stress of delivery plays a central role in the 
physiological dynamics of CRP during the first days of life.14 
15 Actually, we found that the mode of delivery considerably 
influences the values of CRP, which were significantly higher 
in babies born by VD and EMCS than in those born by ELCS. 
This could be explained by the fact that VD is associated with a 
larger production of stress hormones such as cortisol and cate-
cholamines, which in turn are able to affect neutrophil function 
and cytokine production.16 As the current literature suggests, 
delivery stress is related to CRP increase as a consequence of 
the rise of interleukin (IL) 6 and IL-10.17 In fact, VD and EMCS 
share the same pathways of activation of inflammatory response 
in newborn, as previously demonstrated.18 19
To date, numerous studies were performed on the associa-
tion between CRP values and non-infectious conditions in 
newborns; however, data were obtained from populations with 
wide-ranging inclusion criteria (infected, uninfected, symptom-
atic, healthy, at risk, critically ill).20–22 Our study, performed on 
a homogeneous population of healthy term babies, shows that 
CRP reference intervals may be affected by several proinflam-
matory factors, such as PROM, presence of meconium-stained 
amniotic fluid and prolonged labour. An interesting finding is 
related to IAP. There are lots of studies in literature that stress 
the importance of IAP against potential neonatal sepsis.10 23–27 
It seems that its role is maximum only when the prophylaxis 
is done completely. CDC guidelines define as candidates for 
antibiotic prophylaxis the pregnant women who deliver vagi-
nally with positive vaginal swab or uncertain/not performed 
swab in the presence of EOS risk factors. If the offspring is 
not protected by maternal prophylaxis, the EOS risk is greater 
than that of a neonatal population without any infectious risk. 
In consideration of this, the infants with a greater infectious 
risk are candidate to a routine CRP assessment at 48th hour of 
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Figure 3 Median and 5th–95th centiles for neonates born by VD, ELCS 
and EMCS at 48 hours. CRP, C reactive protein; ELCS, elective caesarean 
section; EMCS, emergency caesarean section; VD, vaginal delivery.
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life with a more careful attention to identify early signs and/
or symptoms of sepsis. Certainly, IAP has an influence on CRP 
values trend in the perinatal period: in this study, we found a 
statistically significant difference in CRP values of babies born 
to mothers who had completed the course of IAP, compared 
with newborns whose mothers did not complete the prophy-
laxis.
cOnclusIOns
CRP values undergo a physiological rise after birth. Moreover, 
there are several perinatal factors that may affect the interpre-
tation of CRP values in healthy newborns. In particular, we 
found that mode of delivery has an evident influence on CRP. 
Currently, the most used cut-off value is 10 mg/L. In consider-
ation of the variability of CRP values in healthy term newborns 
related to several factors, it would be appropriate to use normal 
CRP reference values differentiated for gestational age, postnatal 
age and mode of delivery. The use of a static cut-off value, which 
does not reflect the physiological kinetics of CRP, should not 
ensure an adequate diagnostic accuracy.
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